AUTHOR=Xiang Zuojuan , Li Zhengxiong , Chen Xiaojuan , Fu Yingzhou 

TITLE=Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis

JOURNAL=Frontiers in Immunology

VOLUME=Volume 16 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1562875

DOI=10.3389/fimmu.2025.1562875

ISSN=1664-3224